Canadian Urological Association guideline on the management of non-muscle invasive bladder cancer

Bhindi, Bimal; Kool, Ronald; Kulkarni, Girish S.; Aprikian, Armen; Breau, Rodney H.; Brimo, Fadi; Fairey, Adrian; French, Christopher A.; Hanna, Nawar; Izawa, Jonathan I.; Lacombe, Louis; McPherson, Victor; Rendon, Ricardo; Shayegan, Bobby; So, Alan; Zlotta, Alexandre R.; Black, Peter C.; Kassouf, Wassim

doi:10.5489/cuaj.7367

Cited by 18 publications

(20 citation statements)

References 298 publications

(416 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…BMI was investigated in many studies [32]and in the most recent metaanalysis was demonstrated that obese individuals were at higher risk for disease progression (HR 1.88, 95% CI: 1.41, 2.50, n=3) and recurrence (HR 1.60, 95% CI: 1.06, 2.40, n=7) compared to normal BMI patients [33]. Multifocality is a well known predictive factor for NMIBC [34], and its role is even more important in case of CIS. In our cohort, CIS increased both the risk of recurrence and progression.…”

Section: Discussionmentioning

confidence: 99%

Impact of Age on Outcomes of Patients With Pure Carcinoma In Situ of the Bladder: Multi-Institutional Cohort Analysis

Ferro

Chiujdea

Musi

et al. 2022

Clinical Genitourinary Cancer

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Impact of Age on Outcomes of Patients With Pure Carcinoma In Situ of the Bladder: Multi-Institutional Cohort Analysis

Ferro

Chiujdea

Musi

et al. 2022

Clinical Genitourinary Cancer

View full text Add to dashboard Cite

“…Delaying RC by using alternative medical treatments for NMIBC may increase the risk of progression to MIBC and thus has negative implications for survival [2] , [25] . In our study, we presented this to patients as a 25%-point higher risk of death if cancer progressed.…”

Section: Discussionmentioning

confidence: 99%

Patient Preferences for Treatment of Bacillus Calmette-Guérin–unresponsive Non–muscle-invasive Bladder Cancer: A Cross-country Choice Experiment

Collacott

Krucien

Heidenreich

et al. 2023

European Urology Open Science

View full text Add to dashboard Cite

“…This classification detects whether cancer will progress or regress, which will guide the treatment and follow-up of NMIBC. The most important factor in this classification is the grade of cancer 19 . The grade of bladder cancer is divided into three groups: papillary urothelial neoplasia of low malignant potential, low grade, and high grade 13 , 14 .…”

Section: Discussionmentioning

confidence: 99%

Adherence to guidelines in the follow-up of non-muscle-invasive bladder cancer among urology trainers and trainees in Jordan: a cross-sectional study

Al-Azab

Al-Zubi

Demour

et al. 2023

Annals of Medicine &Amp; Surgery

View full text Add to dashboard Cite

Objective: To assess the clinical practice in the follow-up of non-muscle-invasive bladder cancer (NMIBC) among urology specialists (trainers) and residents (trainees) in Jordan. Methods: An electronic questionnaire containing, in addition to demographic data, four questions regarding the follow-up of NMIBC was sent by e-mail to 115 urologists (53 residents and 62 specialists) selected randomly by stratified random sampling from different clinical institutions, 105 of them were returned complete. Results: In all, 105 out of 115 (91%) questionnaires were returned complete. All of the candidates are male. For low-risk NMIBC follow-up, 46 of the specialists (79%) and 35 of the trainees (74%) decided to do a follow-up cystoscopy at 3 months after diagnosis, followed by a check cystoscopy 9 months later than yearly, while for high-risk patients, all of the specialists and 45 of the trainees (96%) decide to do a check cystoscopy every 3 months in the first 2 years after diagnosis. For upper tract follow-up in high-risk NMIBC, all of the urologists in the survey (specialists and trainees) routinely perform upper tract imaging in the form of a computed tomography scan with contrast in the first year after diagnosis. On the other hand, in the follow-up of the upper urinary tract in low-risk NMIBC, 16 of the trainees (34%) and 19 of the specialists (33%) still perform a yearly scan. Conclusion: Because of the high recurrence rate for NMIBC, this raises the importance of adherence to guidelines in the follow-up for these patients and, at the same time to avoid overdoing unnecessary cystoscopies or upper tract scans.

show abstract

Canadian Urological Association guideline on the management of non-muscle invasive bladder cancer

Cited by 18 publications

References 298 publications

Impact of Age on Outcomes of Patients With Pure Carcinoma In Situ of the Bladder: Multi-Institutional Cohort Analysis

Impact of Age on Outcomes of Patients With Pure Carcinoma In Situ of the Bladder: Multi-Institutional Cohort Analysis

Patient Preferences for Treatment of Bacillus Calmette-Guérin–unresponsive Non–muscle-invasive Bladder Cancer: A Cross-country Choice Experiment

Adherence to guidelines in the follow-up of non-muscle-invasive bladder cancer among urology trainers and trainees in Jordan: a cross-sectional study

Contact Info

Product

Resources

About